Why did we switch to a subscription model?
We serve at the pleasure of our readers — a service, like all businesses, that comes with a cost. Publishing the web’s most comprehensive platform for IBD news, columns, patient perspectives and resources requires a significant investment of resources each month for our talented and growing staff of PhD researchers, veteran journalists, talented social media team, and patient columnists.
Unfortunately, there’s no such thing as free digital news and content.
Rather than covering our site with disruptive ads and being obligated to grow page views to satisfy the demands of advertisers (who happen to be the same companies we write about each day), we’ve determined that a low-cost subscription model is the best route to keep high quality, independent content flowing to our audience.
- No more exposure to industry ads.
- No ad retargeting or “creepy” pharma ads following you around the web after visiting IBD News Today
- A low-cost subscription that costs as little as $0.10 a day!
This was a difficult decision, but one we think is necessary to maintaining our journalistic independence and continuing to grow the IBD News platform. We look forward to continuing to serve the IBD community and hope that you’ll join us along the way.
- Access to all content
- Daily news and exclusive interviews
- Weekly patient columns and perspectives
- Mobile and web access
- Ad - free experience
- No creepy ad retargeting